- Stocks
- Healthcare
- NASDAQ: BRKR

Price (delayed)

$63.99

Market cap

$9.69B

P/E Ratio

26.55

Dividend/share

$0.2

EPS

$2.41

Enterprise value

$11.79B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions

BRKR's equity is up by 45% YoY and by 26% QoQ

BRKR's price to earnings (P/E) is 28% lower than its 5-year quarterly average of 37.0 and 7% lower than its last 4 quarters average of 28.6

The net income has declined by 12% since the previous quarter but it is up by 10% year-on-year

BRKR's EPS is down by 12% since the previous quarter but it is up by 11% year-on-year

Bruker's debt has soared by 83% YoY and by 55% from the previous quarter

The quick ratio has decreased by 40% YoY and by 24% from the previous quarter

What are the main financial stats of BRKR

Market
Valuations
Earnings

Shares outstanding

151.39M

Market cap

$9.69B

Enterprise value

$11.79B

Price to earnings (P/E)

26.55

Price to book (P/B)

5.2

Price to sales (P/S)

3.02

EV/EBIT

25.86

EV/EBITDA

19.66

EV/Sales

3.78

Revenue

$3.12B

EBIT

$455.9M

EBITDA

$599.7M

Free cash flow

$169.4M

Per share
Balance sheet
Liquidity

EPS

$2.41

Free cash flow per share

$1.15

Book value per share

$12.31

Revenue per share

$21.16

TBVPS

$23.3

Total assets

$5.9B

Total liabilities

$4.08B

Debt

$2.27B

Equity

$1.79B

Working capital

$848.5M

Debt to equity

1.27

Current ratio

1.65

Quick ratio

0.59

Net debt/EBITDA

3.5

Margins
Efficiency
Dividend

EBITDA margin

19.2%

Gross margin

49.7%

Net margin

11.3%

Operating margin

10.9%

Return on assets

7.6%

Return on equity

24.3%

Return on invested capital

13.8%

Return on capital employed

9.9%

Return on sales

14.6%

Dividend yield

0.31%

DPS

$0.2

Payout ratio

8.3%

How has the Bruker stock price performed over time

Intraday

1.06%

1 week

-0.62%

1 month

3.21%

1 year

2.8%

YTD

-12.92%

QTD

0.28%

How have Bruker's revenue and profit performed over time

Revenue

$3.12B

Gross profit

$1.55B

Operating income

$340.9M

Net income

$352.1M

Gross margin

49.7%

Net margin

11.3%

BRKR's operating margin is down by 37% YoY and by 13% QoQ

BRKR's operating income is down by 28% year-on-year and by 10% since the previous quarter

Bruker's net margin has decreased by 16% from the previous quarter and by 4.2% YoY

Bruker's revenue has increased by 15% YoY and by 4% QoQ

What is Bruker's growth rate over time

What is Bruker stock price valuation

P/E

26.55

P/B

5.2

P/S

3.02

EV/EBIT

25.86

EV/EBITDA

19.66

EV/Sales

3.78

BRKR's price to earnings (P/E) is 28% lower than its 5-year quarterly average of 37.0 and 7% lower than its last 4 quarters average of 28.6

BRKR's EPS is down by 12% since the previous quarter but it is up by 11% year-on-year

BRKR's equity is up by 45% YoY and by 26% QoQ

The stock's price to book (P/B) is 40% less than its 5-year quarterly average of 8.7 and 29% less than its last 4 quarters average of 7.3

The stock's price to sales (P/S) is 23% less than its 5-year quarterly average of 3.9 and 16% less than its last 4 quarters average of 3.6

Bruker's revenue has increased by 15% YoY and by 4% QoQ

How efficient is Bruker business performance

BRKR's return on assets is down by 22% since the previous quarter and by 14% year-on-year

Bruker's return on equity has decreased by 21% QoQ and by 15% YoY

Bruker's return on invested capital has decreased by 21% QoQ and by 19% YoY

BRKR's return on sales is down by 14% since the previous quarter and by 9% year-on-year

What is BRKR's dividend history

DPS

$0.2

Dividend yield

0.31%

Payout ratio

8.3%

Recent dividends

Special dividends are included in TTM DPS and yield

How did Bruker financials performed over time

BRKR's total assets is 45% greater than its total liabilities

BRKR's total liabilities has soared by 56% YoY and by 33% QoQ

BRKR's total assets has surged by 53% year-on-year and by 31% since the previous quarter

Bruker's debt is 27% more than its equity

Bruker's debt has soared by 83% YoY and by 55% from the previous quarter

BRKR's equity is up by 45% YoY and by 26% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.